Impact for industry
This programme will revolutionise medical design and pre-operative planning, boosting the UK healthcare technologies sector and having enormous economic impact.
The programme will have impact in the area of in silico clinical trials for new drugs, medical devices and biotechnology products. Implementation of in silico clinical trials for new orthopaedic and tissue engineering implants, including modelling the variability of populations will provide a more accurate pre-clinical assessment for musculoskeletal devices and better prediction of the clinical outcomes of those new devices.
Aiming to create a new generation of predictive models capable of handling complex multi-scale and multiphysics problems, characterised by uncertain and incomplete information.